Mycotopia ApS
CVRCVR number44968576
Company financials
Key figures
Updated 2 Jun 2026
- Return on assets
- -0.5%
- Return on equity
- 82%
- Current ratio
- 15.1%
- Equity ratio
- 19.9%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -10,396 |
Operating profit | -10,396 |
Finance expenses | 139,792 |
Profit/loss for the year | 329,812 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 0 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 60,282 |
Current assets | 60,282 |
Non-current assets | 1,961,805 |
Total assets | 2,022,087 |
Equity | 402,087 |
Liabilities | 1,620,000 |
Current liabilities | 398,611 |
Working capital
| Reporting period | |
|---|---|
Trade payables | 6,250 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,000 |
Retained earnings | 362,087 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 1,961,805 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets væsentligste aktivitet har i regnskabsåret bestået af at erhverve og eje unoterede kapitalandele.
Development in activities and financial affairs
Der har ikke været væsentlige ændringer i aktiviteter og økonomiske forhold.
Årets resultat anses for tilfredsstillende.